IDEXX Laboratories, Inc.
IDXX
$430.12
$1.090.25%
| Weiss Ratings | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C | |||
| Rating Factors | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.16 | |||
| Price History | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.05% | |||
| 30-Day Total Return | -0.51% | |||
| 60-Day Total Return | -1.28% | |||
| 90-Day Total Return | -4.90% | |||
| Year to Date Total Return | 5.20% | |||
| 1-Year Total Return | -23.63% | |||
| 2-Year Total Return | -9.26% | |||
| 3-Year Total Return | -16.85% | |||
| 5-Year Total Return | 77.13% | |||
| 52-Week High % Change | -25.38% | |||
| 52-Week Low % Change | 7.66% | |||
| Price | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $574.94 | |||
| 52-Week Low Price | $398.50 | |||
| 52-Week Low Price (Date) | Nov 21, 2024 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 34.89B | |||
| Enterprise Value | 35.59B | |||
| Price/Earnings (TTM) | 40.21 | |||
| Earnings Per Share (TTM) | 10.67 | |||
| Earnings Per Share Growth | 6.06% | |||
| Price/Earnings To Growth | 6.64 | |||
| Price/Sales (TTM) | 9.09 | |||
| Price/Book (Q) | 21.95 | |||
| Enterprise Value/Revenue (TTM) | 9.13 | |||
| Price | $430.12 | |||
| Enterprise Value/EBITDA (TTM) | 25.77 | |||
| Enterprise Value/EBIT | 28.44 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 82.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 207 556 0300 | |||
| Address | One IDEXX Drive Westbrook, ME 04092 | |||
| Website | www.idexx.com | |||
| Country | United States | |||
| Year Founded | 1983 | |||
| Profitability | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 32.10% | |||
| Profit Margin | 22.78% | |||
| Management Effectiveness | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 23.87% | |||
| Return on Equity | 57.66% | |||
| Income Statement | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.90B | |||
| Total Revenue (TTM) | 3.90B | |||
| Revenue Per Share | $47.22 | |||
| Gross Profit (TTM) | 2.38B | |||
| EBITDA (TTM) | 1.38B | |||
| EBIT (TTM) | 1.25B | |||
| Net Income (TTM) | 887.87M | |||
| Net Income Avl. to Common (TTM) | 887.87M | |||
| Total Revenue Growth (Q YOY) | 5.84% | |||
| Earnings Growth (Q YOY) | 11.12% | |||
| EPS Diluted (TTM) | 10.67 | |||
| EPS Diluted Growth (Q YOY) | 13.41% | |||
| Balance Sheet | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 288.27M | |||
| Cash Per Share (Q) | $3.49 | |||
| Total Current Assets (Q) | 1.40B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.60B | |||
| Current Ratio (Q) | 1.311 | |||
| Book Value Per Share (Q) | $19.55 | |||
| Total Assets (Q) | 3.29B | |||
| Total Current Liabilities (Q) | 1.07B | |||
| Total Debt (Q) | 986.95M | |||
| Total Liabilities (Q) | 1.70B | |||
| Total Common Equity (Q) | 1.60B | |||
| Cash Flow | IDXX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -207.06M | |||
| Cash from Financing (TTM) | -878.07M | |||
| Net Change in Cash (TTM) | -165.67M | |||
| Levered Free Cash Flow (TTM) | 773.39M | |||
| Cash from Operations (TTM) | 929.00M | |||
